Skip to content
The Nexus
DossierENTITY

Arvinas

Coverage of Arvinas in the Nexus archive.

Earliest in view: May 28 · 08:30 UTCMost recent: May 28 · 08:30 UTC
Co-mentioned in this coverage
Baxfendytopic1Awiqlitopic1Veppanutopic1AstraZenecaorganization1Novo Nordiskorganization1Pfizerorganization1Rigel Pharmaceuticalsorganization1Trumpperson1most-favored-nation dealstopic1
Recent coverage
  • HEALTHMay 28 · 08:30 UTCSTAT NEWS
    STAT+: Trump’s drug-pricing deals set to be tested by new product launches

    President Trump's most-favored-nation drug pricing deals with 17 drugmakers will be tested by three new prescription drugs set to launch soon. The drugs, Baxfendy (hypertension), Awiqli (insulin), and Veppanu (cancer), will offer the first public insight into the practical impacts of these secretive pricing agreements.